Evidence map

TrialThe lancet. Diabetes & endocrinology2023

Safety and effectiveness of metformin plus lifestyle intervention compared with lifestyle intervention alone in preventing progression to diabetes in a Chinese population with impaired glucose regulation: a multicentre, open-label, randomised controlled trial.

Lihui Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

44 papers cite it

2023
2024
2025
2026
this paperpooled ittrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 37414069